MorphoSys AG (WBO:MOR)
€ 67.6 0.8 (1.2%) Market Cap: 2.52 Bil Enterprise Value: 2.48 Bil PE Ratio: 0 PB Ratio: 52.00 GF Score: 59/100

MorphoSys AG at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 09:30PM GMT
Release Date Price: €117.7 (-2.08%)
James Daniel Gordon
JP Morgan Chase & Co, Research Division - Senior Analyst

Good afternoon. I'm James Gordon, JPMorgan European pharma biotech analyst, and today, I've got the pleasure of introducing the MorphoSys presentation. So you're going to hear from MorphoSys' CEO, Jean-Paul Kress, and we're going to have a breakout after this in the Yorkshire Room, so I hope you can join us for the Q&A then.

So with that said, thank you very much for joining us. And I look forward to the presentation.

Jean;Paul Kress
MorphoSys AG - CEO & Management Board Member

Thanks, James. Good afternoon. Pleasure to be here and to share with you our great progress at MorphoSys. These are very exciting times for us at MorphoSys as we are very well positioned for success and value creation. So our forward-looking statement slide.

A few years ago, we initiated a transformation from a leading technology provider deeply rooted in science to a fully integrated biopharma company in command of the whole value chain and focusing on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot